Azurocidin, Human, ELISA kit – 1 x 96 det. - HK352-01
Quantity
1 x 96 det.
Catalog #
HK352-01
778,00 €
Azurocidin, also called heparin-binding protein (HBP) or cationic antimicrobial protein of 37 Kda (CAP37), is an inactive homolog of serine proteinases residing in granulocytes. Initially it was thought to have only activity against gram-negative bacteria. Later it was also found to act against gram-positive bacteria and C.albicans. Azurocidin is considered a family member of polymorphonuclear leukocytes- derived antimicrobial proteins like defensins, LL-37 and lysozyme. Azurocidin has been recognized as a player in the activation and modulator of the immune response and may act to alarm the immune system. The cationic domain at one side of the protein is essential for its antimicrobial activity. It is stored in azurophil granules as well as secretory granules and as a result partly released at early stage of extravasation. Azurocidin is involved in chemotaxis and activation of monocytes, cytokine release and phagocytosis leading to more efficient bacterial clearance. The primary targeted environment of azurocidin are cells in the bloodstream, that is the endothelial lining, and the extravascular surroundings. The interaction of azurocidin with leucocytes is mediated via β2-intergrins.
| Datasheet URL | https://www.hycultbiotech.com/wp-content/uploads/2022/06/HK352-0816.pdf |
|---|---|
| Quantity | 1 x 96 det. |
| Quantity | 1 x 96 det. |
| Standard range | Measurable concentration range of 1.6 to 100 ng/ml. |
| Detection level | Minimum concentration which can be measured is 1.6 ng/ml. |
| Working volume | 100 µl/well |
| Species | human |
| Cross reactivity | Horse - No, Mouse - No, Pig - No, Rabbit - No, Rat - No |
| Alias | cationic antimicrobial protein CAP37, heparin-binding protein, HBP |
| Application | The human Azurocidin ELISA kit is to be used for the in vitro quantitative determination of human azurocidin in plasma, serum and sputum samples. |
| Principle | The human Azurocidin ELISA is a ready-to-use solid-phase enzyme-linked immunosorbent assay based on the sandwich principle with a working time of 3½ hours. The efficient format of a plate with twelve disposable 8-well strips allows free choice of batch size for the assay. Samples and standards are incubated in micro titer wells coated with antibodies recognizing human Azurocidin. Biotinylated tracer antibody will bind to captured human Azurocidin. Streptavidin-peroxidase conjugate will bind to the biotinylated tracer antibody. Streptavidin-peroxidase conjugate will react with the substrate, tetramethylbenzidine (TMB). The enzyme reaction is stopped by the addition of oxalic acid. The absorbance at 450 nm is measured with a spectrophotometer. A standard curve is obtained by plotting the absorbance (linear) versus the corresponding concentrations of the human Azurocidin standards (log). The human Azurocidin concentration of samples, which are run concurrently with the standards, can be determined from the standard curve. |
| Storage and stability | Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least six months. |
| Precautions | For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and Federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result with the use of or derivation of this product. |
| Disease | Infectious diseases |
| Application assays: | The human Azurocidin ELISA kit is to be used for the in vitro quantitative determination of human azurocidin in plasma, serum and sputum samples. |
|---|---|
| Principle: | The human Azurocidin ELISA is a ready-to-use solid-phase enzyme-linked immunosorbent assay based on the sandwich principle with a working time of 3½ hours. The efficient format of a plate with twelve disposable 8-well strips allows free choice of batch size for the assay. Samples and standards are incubated in micro titer wells coated with antibodies recognizing human Azurocidin. Biotinylated tracer antibody will bind to captured human Azurocidin. Streptavidin-peroxidase conjugate will bind to the biotinylated tracer antibody. Streptavidin-peroxidase conjugate will react with the substrate, tetramethylbenzidine (TMB). The enzyme reaction is stopped by the addition of oxalic acid. The absorbance at 450 nm is measured with a spectrophotometer. A standard curve is obtained by plotting the absorbance (linear) versus the corresponding concentrations of the human Azurocidin standards (log). The human Azurocidin concentration of samples, which are run concurrently with the standards, can be determined from the standard curve. |
Diese Artikel könnten Ihnen eventuell auch gefallen!
